Fraunhofer Institute for Toxicology and Experimental MedicineThe Advisory Board of the individual Fraunhofer Institutes act as purely advisory bodies to their institute’s management. The members come from academia, industry, and government agencies.
Advisory Board
The Advisory Board of Fraunhofer ITEM
As of February 2025
Chairman
Prof. Clive Page, OBE, Ph.D.Emeritus Professor of Pharmacology, School of Cancer and Pharmaceutical Science, King’s College London (UK) |
Members
Dr. Karin Conde-KnapeSenior Vice President Global Drug Discovery, Novo Nordisk A/S (Denmark) |
Prof. Susanne HeroldDirector of the Clinic for Infectiology and Hospital Hygiene, University Hospital Giessen and Marburg |
Prof. Edith M. HesselChief Scientific Officer, Relation Therapeutics (UK) |
Prof. Ralf HussManaging of BioM BioTech Cluster Development GmbH, Munich |
Prof. Paul-Georg GermannGlobal Head and Vice President of Chemical and Preclinical Safety (CPS), Biopharma, R&D, Discovery and Development Technologies, Merck Healthcare KGaA |
Prof. Denise Hilfiker-Kleiner, Ph.DPresident and Board Member for Research and Education, Hannover Medical School |
Dr. Eckhard SchwennerCEO Health-I Business Consulting |
Anna TeschnerHead of the Division of Life Sciences, Humanities, Social Sciences and Academic Libraries, Lower Saxony Ministry of Science and Culture |
Dr. Tewes TralauHead of Department Pesticides Safety, German Federal Institute for Risk Assessment (BfR) |